Brief: Aethlon Medical Receives Ethics Board Approval To Add Second Site To Ongoing Clinical Trial Of Its Hemopurifier
22/05/2023 13:49
May 22 (Reuters) - Aethlon Medical Inc AEMD.O :
* AETHLON MEDICAL RECEIVES ETHICS BOARD APPROVAL TO ADD
SECOND
SITE TO ITS ONGOING CLINICAL TRIAL OF ITS HEMOPURIFIER® TO TREAT
SEVERE COVID-19 IN INDIA
Source text for Eikon: ID:nPnby9MHwa
Further company coverage: AEMD.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology